CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $219,000 | -4.4% | 9,194 | -30.1% | 0.02% | -32.0% |
Q3 2020 | $229,000 | -39.6% | 13,159 | -53.6% | 0.02% | -13.8% |
Q4 2018 | $379,000 | -17.8% | 28,358 | -7.6% | 0.03% | 0.0% |
Q3 2018 | $461,000 | +14.7% | 30,701 | +20.2% | 0.03% | +20.8% |
Q2 2018 | $402,000 | – | 25,550 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |